Daotian Fu

President

Dr. Fu Daotian has over 28 years of experience training and working in the biopharmaceutical industry in the United States. He has deep knowledge of CMC development of clinical stage programs, and was involved in the global launch of five major biologics and clinical development of multiple R&D programs. Prior to RemeGen, Dr. Fu was vice president and executive director of Livzon Pharmaceutical Group and general manager of Livzon Mabpharm, Inc., where he was in charge of the development of biologics portfolio. There he oversaw the successful submission of a new drug application (NDA), while advancing the company’s clinical development projects. From 1998 to 2012, Dr. Fu served as the Vice President of R&D at Genzyme Corp., responsible for CMC development of clinical stage programs, and was directly involved in global launch of five major biologics and clinical development of multiple R&D programs. Dr. Fu received his Ph.D. from Iowa State University.